SURVEILLANCE FOR THE DETECTION OF EARLY-STAGE PANCREATIC CANCER IN INDIVIDUALS WITH RISK FOR FAMILIAL PANCREATIC CANCER AND HEREDITARY PANCREATIC CANCER SYNDROME

DOI
  • HIJIOKA Susumu
    Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital.
  • MORIZANE Chigusa
    Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital.
  • SAITO Yutaka
    Endoscopy Division, National Cancer Center Hospital.

Bibliographic Information

Other Title
  • 家族性膵癌家系ならびに遺伝性膵癌症候群に対する早期膵癌発見を目指したサーベイランス　～世界の動向～

Search this article

Description

<p>The high-risk groups for pancreatic cancer include those with a history of pancreatic cancer, familial pancreatic cancer, hereditary pancreatitis, or hereditary pancreatic cancer syndrome. Familial pancreatic cancer is defined as having a history of two or more first-degree relatives with pancreatic cancer. Surveillances for the early detection of pancreatic cancer in individuals at risk are being conducted worldwide. In particular, the Cancer of the Pancreas Screening (CAPS), which is mainly conducted in the United States, has a policy of surveillance based on endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI). There are many similar methods available worldwide with various reports on their usefulness.</p><p>In Japan, expert consensus statements have been issued and multicenter prospective intervention studies have been initiated.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top